BETHESDA, Md. (AP) — BETHESDA, Md. (AP) — Northwest Biotherapeutics Inc. (NWBO) on Tuesday reported a loss of $19.4 million in its third quarter.

On a per-share basis, the Bethesda, Maryland-based company said it had a loss of 2 cents.

The cancer drug developer posted revenue of $357,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NWBO at https://www.zacks.com/ap/NWBO